abstract |
This invention relates to compounds of the Formula (I): n nor a pharmaceutically acceptable salt, solvate or isomer thereof, wherein n, M, V, T, W, X, U, R 1 and R 2 are as disclosed in the present specification, and which compounds are useful for the treatment of diseases or conditions mediated by MMPs, TNF-α or combinations thereof. |